Marker | Expression level |
---|
CgA | + + +* |
synaptophysin | = |
NSE | + |
CD56 | + +* |
Ki-67 | − − −* |
PCNA | = |
DAXX | = |
CD24 | −* |
CD44 | −* |
CD31 | − −* |
CD45 | +* |
Vimentin | + |
β-catenin | + +* |
MENA | − −* |
CD49 | −* |
Laminin | = |
ECAD | − −* |
PCAD | − − −* |
EpCAM | − −* |
CDX2 | − −* |
PDX1 | + +* |
CD14 | = |
CK6 | − −* |
CK7 | − − −* |
CK13 | −* |
CK20 | + +* |
P53 | + +* |
- + and − indicates whether marker mRNA transcript levels are higher or lower in the tumour tissue compared to the matched no-tumour tissue. *Represents significant changes (p < 0.05)
- −: 1–twofold change lower compared to normal; − −: 2–tenfold change lower compared to normal; − − −: > tenfold change lower compared to normal; +: 1–twofold change higher relative to normal; + +: 2–tenfold change higher relative to normal; + + +: > tenfold change relative to normal; =: similar in tumour and non-tumour